ArticlePCN reports : psychiatry and clinical neurosciences2026

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Masaki Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.